Brian Di Donato

Brian Di Donato is the Vice President, Investor Relations & Corporate Communications at Achillion Pharmaceuticals. Brian has over 20 years of experience in the financial industry, including positions at Morgan Stanley, UBS Securities, and Sorin Capital Management. Brian has also served as an adjunct associate professor of business at the Villanova School of Business and as the Chief Financial Officer of Immunocore. In January 2020, they were acquired by Alexion Pharmaceuticals for $1.2B.

Brian Di Donato has a MBA in Finance from NYU Stern School of Business, a BS in Biology- Genetics & Developmental Biology from Penn State Abington, and a BSME in Engineering from Villanova University.

Their manager is Joseph Truitt, President & CEO. They are on a team with Anthony S. Gibney - Executive Vice President, Chief Business Officer, Kevin P. Malobisky - SVP Global Regulatory Affairs and Quality & Compliance, and Martha Manning - Executive Vice President, General Counsel and Secretary.